Wockhardt Receives FDA Approval to Sell Generic Aricept

Lower prices for generic Aricept should allow more Alzheimer's patients to receive the drug...
By Bob DeMarco
Alzheimer's Reading Room

What is
Alzheimer's disease?

Pharmaceutical and biotechnology company Wockhardt has received tentative approval from the United States Food and Drug Administration (FDA) to market and sell 5mg and 10mg tablets of Donepezil HCl, which is used for treatment of Alzheimer’s disease and dementia.

Donepezil is the generic name for the brand Aricept®, marketed in the United States by Eisai in partnership with Pfizer. Wockhardt will be launching the product in the US market on May 28, 2011. According to IMS Health, the total market for this product in the US is about $2.5 billion.

Read More on the Alzheimer's Reading Room

Communicating in Alzheimer's World

What’s the Difference Between Alzheimer’s Disease and Dementia

How the Loss of Memory Works in Alzheimer’s Disease, and How Understanding This Could Help You

Learning How to Communicate with Someone Suffering From Alzheimer's Disease

What is Alzheimer's Disease?

What is Dementia?

Alzheimer's World -- Trying to Reconnect with Someone Suffering from Alzheimer's Disease

Advice and Insight -- Alzheimer's Reading Room

Dementia and the Eight Types of Dementia

Does the Combination of Aricept and Namenda Help Slow the Rate of Decline in Alzheimer's Patients

Test Your Memory (TYM) for Alzheimer's or Dementia in Five Minutes

The Mini-Cog Test for Alzheimer's and Dementia

Alzheimer's Disease, Urinary Tract Infections, Urinary Incontinence, Poop (8 Articles)

100 Good Reasons to Subscribe to the Alzheimer's Reading Room Now

Bob DeMarco is the Founder of the Alzheimer's Reading Room and an Alzheimer's caregiver. The blog contains more than 2,560 articles with more than 412,100 links on the Internet. Bob resides in Delray Beach, FL.